[Iatrogenic mycoses with deep visceral localization caused by opportunistic fungi].
The new therapeutic methods based on antibiotics, corticosteroids and immunosuppressors and the new medicosurgical techniques (catheters, monitoring in intensive-care units, open-heart surgery) modify the host, favorise the adaptation and introduction f endogenous and exogenous yeast-like fungi and thus create a new pathology characterized by deep visceral or septicemic infections due to yeasts belonging to the genera Candida, Torulopsis, Cryptococcus, Trichosporon, Rhodotorula, and Saccharomyces. The pathological aspects are analyzed and therapy is suggested in the light of new findings on polyenes (nystatine, amphotericine B), 5-fluorocytosine, imidazole, derivatives (miconazole, econazole) considering their association in function of synergy or antagonism possibilities.
D000666:Amphotericin B / Q000627:therapeutic use; D002175:Candida; D002177:Candidiasis / Q000209:etiology; D003453:Cryptococcosis / Q000209:etiology; D003881:Dermatomycoses / Q000209:etiology; D004696:Endocarditis / Q000209:etiology; D005437:Flucytosine / Q000627:therapeutic use; D006801:Humans; D007049:Iatrogenic Disease; D007093:Imidazoles / Q000627:therapeutic use; D008172:Lung Diseases, Fungal / Q000209:etiology; D009181:Mycoses / Q000188:drug therapy / Q000209:etiology* / Q000382:microbiology; D009761:Nystatin / Q000627:therapeutic use; D010000:Osteitis / Q000209:etiology; D018805:Sepsis / Q000188:drug therapy / Q000209:etiology / Q000382:microbiology; D014552:Urinary Tract Infections / Q000209:etiology
D007093:Imidazoles; D009761:Nystatin; D000666:Amphotericin B; D005437:Flucytosine
Mycoses iatrogènes à localisation profonde dues à des champignons levuriformes opportunistes.